ArriVent BioPharma, Inc.

Q1 2026 13F Holders

Symbol: AVBP
CUSIP: 04272N102
Type: Equity
Class: COM
Num filings: 146
Total reported value, excl. options: $969 M

Compare 2026 Q1 to

Manager	Report Date	Value ($000)	Shares	Option Type